Pharmaceuticals

‘As long as it is for free’

By Lucien Hordijk & Daan Marselis Most of the demand for (refresher) training courses for doctors in the Netherlands is fulfilled by industry- sponsored programmes. …

Pharmaceuticals

From blockbuster to nichebuster

Two decades of EU market protection of ‘orphan’ (rare disease) medicines have greatly benefitted the industry. According to research by The Investigative Desk, published in …

Pharmaceuticals

EMA rewrites medicine approval policy

New innovative medicines should be made available to European citizens more quickly. That is why the European Medicines Agency updates the process for market authorisation. …